Relapsed and/or Refractory Multiple Myeloma
Oncology·MeSH: Multiple Myeloma
9 drugs in development·5 companies·2 clinical trials
Drug Pipeline by Phase
Approved(1)
Phase 3(4)
Phase 2(1)
| Drug | Company |
|---|---|
| iberdomide | CELGENE CORP /DE/ (CELG) |
Phase 1(1)
Phase 1/Phase 2(1)
Phase 2/Phase 3(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Relapsed and/or Refractory Multiple Myeloma?
BioSniper tracks 9 drugs in development for Relapsed and/or Refractory Multiple Myeloma across 5 companies.
How many clinical trials target Relapsed and/or Refractory Multiple Myeloma?
There are 2 clinical trials targeting Relapsed and/or Refractory Multiple Myeloma tracked by BioSniper.
Deep-dive into Relapsed and/or Refractory Multiple Myeloma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis